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ABSTRACT
Preharvest intervention strategies to reduce Escherichia coli 0157:H7 in cattle have been sought as a means to reduce
human foodborne illness. A blinded clinical trial was conducted to test the effect of a vaccine product on the probability that
feedlot steers, under conditions of natural exposure, shed E. coli 0157:H7 in feces, are colonized by this organism in the
terminal rectum, or develop a humoral response to the respective antigens. Steers (n = 288) were assigned randomly to 36
pens (eight head per pen), and pens were randomized to vaccination treatment in a balanced fashion within six dietary
treatments of an unrelated nutrition study. Treatments included vaccination or placebo (three doses at 3-week intervals). Fecal
samples for culture (n = 1,410) were collected from the rectum of each steer on pretreatment day 0 and posttreatment days
14, 28,42, and 56. Terminal rectum mucosal (TRM) cells were aseptically collected for culture at harvest (day 57 posttreatment)
by scraping the mucosa 3.0 to 5.5 cm proximal to the rectoanal junction. E. coli 0157:H7 was isolated and identified with
selective enrichment, immunomagnetic separation, and PCR confirmation. Vaccinated cattle were 98.3% less likely to be
colonized by E. coli 0157:H7 in TRM cells (odds ratio = 0.014, P < 0.0001). Diet was also associated with the probability
of cattle being colonized (P = 0.04). Vaccinated cattle demonstrated significant humoral responses to Tir and 0157 lipopolysaccharide. These results provide evidence that this vaccine product reduces E. coli 0157:H7 colonization of the terminal
rectum of feedlot beef cattle under conditions of natural exposure, a first step in its evaluation as an effective intervention for
food and environmental safety.

Escherichia coli 0157:H7 is an important foodborne,
zoonotic pathogen of humans (1, 3, 60). This organism is
the prototype of the enterohemorrhagic E. coli class, organisms that characteristically cause hemorrhagic colitis
and hemolytic uremic syndrome in humans (32). Enterohemorrhagic E. coli strains produce a type of Shiga toxin
(Stx), which has a principal function in the causation of
vascular damage (60). In addition, these strains produce attaching-effacing lesions in the intestines, which contribute
to the pathogenesis (26, 39). Stx is produced not only by
serotype 0157:H7, but also by many other serotypes of E.
coli that are consequently referred to as Shiga toxin-producing E. coli (31, 48). Nearly 500 0 serotypes of Shiga
toxin-producing E. coli have been isolated from humans
with disease; however, <10 cause the majority of cases
(21). Hence, based on the importance of Stx as a virulence
factor (31, 60), Shiga toxin-producing E. coli is considered
a potential pathogen for humans, although it is likely that
not all strains have the ability to cause disease, because the
pathogenesis is multifactorial and involves multiple virulence factors (21, 31, 48).

* Author
t

for correspondence. Tel: 402-472-2362; Fax: 402-472-9690;
E-mail: dsmith8 @unl.edu.
Contribution from the University of Nebraska Agricultural Research Division, Lincoln, journal series 14698.

In the United States, ground beef is the most common
vehicle associated with foodborne outbreaks of E. coli
0157:H7 (2, 7). Cattle are an asymptomatic reservoir of
this microorganism and shed it in the feces (38, 55, 59).
Fecal material is an important source of infection for humans, who most often acquire the organism in contaminated food and water or by direct contact with carrier animals
(1, 8, 52, 55). The proportion of cattle carrying E. coli
0157:H7 in the feces or on hides is correlated with postharvest rates of carcass contamination with the same organism (16). Preharvest strategies to prevent foodborne illness in humans, e.g., reduction of the prevalence of cattle
shedding E. coli 0157:H7 in their feces, have been proposed early on to prevent foodborne illness (10, 22), and
this has become a major focus of research groups around
the world (6, 35, 59).
Bacterial virulence mechanisms important in intestinal
colonization are a logical target for intervention strategies.
The outer membrane protein intimin (Eae) and the type 111
secreted proteins, including but not limited to the translocated-intimin receptor (Tir) and E. coli-secreted proteins
([Esp] A and B), are bacterial proteins that mediate the
formation of attaching-effacing lesions (23). These proteins
are encoded on a pathogenicity island called the locus of
enterocyte effacement (LEE) (17). After E. coli 0157:H7
contacts a mucosal epithelial cell in the intestine, it delivers
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Tir, EspB, and other type I11 secreted proteins into the cell
through a transiently produced translocation tube (44),
which structurally consists of an assembly of EspA subunits
(17). A series of cytoskeletal alterations resulting in effacement of the rnicrovilli and pedestal formation at the site of
bacterial attachment ensues (53). Subsequently, intimin is
bound to Tir, which is integrated into the host cell membrane, and this effects intimate attachment (13).
The relationship and relevance of attaching-effacing lesions to intestinal colonization have been demonstrated by
mutagenesis studies. Inactivation of the gene encoding intimin (eae) in E. coli 0157:H7 has significantly reduced
enteritis and bacterial fecal shedding in experimentally infected neonatal calves ( I I ) and colonization and fecal shedding in yearling cattle (9). Similarly, experimental challenge of calves with an E. coli 0157:H7 strain containing
a deletion in the operon (LEE4) that encodes the type I11
secreted proteins resulted in reduced colonization and fecal
shedding (42).
Human patients with E. coli 0 157:H7-associated disease (e.g., hemolytic uremic syndrome) were found to develop a robust serum antibody response to Tir (34, 65), and
based on this observation, the hypothesis was raised that
type I11 secreted proteins would make a suitable vaccine
target for this pathogen in humans and cattle (34). Subsequent studies demonstrated that a vaccine prepared from
culture supernatant materials enriched with type I11 secreted
proteins has significant potential as a preharvest intervention strategy for E. coli 0157:H7 (50). However, to our
knowledge, the effect of this vaccine on colonization of the
terminal rectum has not previously been tested.
The reduction in colonization and fecal shedding in
experimentally infected calves that result from the deletion
of the LEE4 ODeron in the E. coli 0157:H7 strain was concluded to provide a proof of concept for the utilization of
type 111 secreted proteins as a vaccine strategy (42). However, some studies have not found vaccination to be efficacious. One of these utilized type 111 secreted proteins as
the vaccine antigen, although they were formalin treated,
which may have altered the immunogenicity of the vaccine
(63). A recent study involved vaccinating young calves < 1
month old by the intramuscular route with subunit intimin28o-, Efa- 1', and enterohemorrhagic E. coli bacterin, singularly or in combination, and then boosting by intranasal
exposure with the same antigens with cholera toxin B subunit as an adjuvant (62). Although the calves developed
humoral antibodies and some developed salivary immunoglobulin A (IgA) antibodies to the homologous antigen,
they were not protected against intestinal colonization by
E. coli 0157:H7 following experimental challenge (62).
The objectives of this clinical trial were to test, under
conditions of natural exposure, the effect of a vaccine containing E. coli type I11 secreted proteins on (i) the probability that feedlot steers shed E. coli 0157:H7 in the feces,
(ii) the probability that feedlot steers are colonized by this
organism in the terminal rectum, (iii) the growth performance of cattle, and (iv) the humoral immune responses to
the respective antigens.

2569

MATERIALS AND METHODS
Source of cattle. Two hundred eighty-eight crossbred steers
were obtained in the fall of 2003 and grown in a winter-grazing
system until they were placed in their respective treatment pens
on day 1 of the trial (19 May 2004). Prior to day 1 of the trial,
steers were limit fed a 50% alfalfa hay:50% wet corn gluten feed
diet on a dry matter (DM) basis at 2% body weight (BW) for 5
consecutive days to reduce variation in initial weight due to gut
fill. Initial BWs (352 2 11 [SD] kg) were calculated as the average of weights taken the last 2 days of the 5-day limit-fed period.
Study design. Upon completion of the first weigh day, steers
were stratified by BW so that the heaviest 36 cattle could be
assigned within their weight strata to 36 pens with a random number generator. This randomization process was repeated seven
times so that each pen housed a total of eight steers with initial
BW distributed evenly among the 36 pens.
Six pens were assigned to each of six dietary treatments with
a random number generator in a balanced fashion. Six levels of
dietary treatments evaluated the level of wet distillers' grains plus
solubles (DG) on cattle performance as follows: (i) 0% DG
(OODG), (ii) 10% DG (IODG), (iii) 20% DG (20DG), (iv) 30%
DG (30DG), (v) 40% DG (40DG), and (vi) 50% DG (50DG), all
included in the rations as a percentage of DM. Alfalfa hay was
included in all diets at 5.0% of DM, and high-moisture corn and
dry-rolled corn were fed at a 1:1 ratio (DM basis). DG replaced
corn in each treatment diet.
Vaccination treatments were assigned randomly within dietary treatment in a balanced fashion, so that within each group of
six pens of a dietary treatment, three were randomly assigned to
receive one of two vaccine treatments (total of I8 pens per vaccination treatment). The vaccine (2 ml Der dose: Bioniche Life
Sciences, Belleville, Ontario, Canada) was administered subcutaneously in the neck with an 1%gauge, 1.6-cm needle. The vaccine
contained secreted proteins prepared from E. coli 0157:H7 as previously described (34, 50) and was formulated with the adjuvant
Emulsigen D (MVP Laboratories, Omaha, Nebr.) such that the
protein concentration was 66.1 J . L ~ per dose. Vaccination treatments were coded A (vaccination) and B (placebo), so that all
feedlot and laboratory personnel were blinded to treatments until
after completion of the study. All steers received three doses of
the vaccine or placebo (adjuvant only) at 21-day intervals on days
28, 49, and 70 of the 126-day feeding period. The study timeline
is summarized in Table 1.
Management, sampling procedures, and carcass data collection. Feedlot personnel visually evaluated feedbunks each
morning to assign a daily allotment of feed to each pen of cattle.
Additionally, experienced animal health personnel visually appraised cattle three times each week to evaluate health status.
Feces were collected per rectum from each steer on day 28
of the feeding period and every 14 days following completion of
the three-dose regimen, resulting in one pretreatment sample (day
28 of the feeding period) and four test-period samplings at days
84, 98, 112, and 126 of the feeding period (14, 28, 42, and 56
days following completion of the three-dose regimen). Individual
BWs were collected concurrently with fecal sampling.
Serum samples were collected from cattle on days 28, 84,
and 126 of the feeding period (pretreatment and 14 and 56 days
following completion of the three-dose regimen). Enzyme-linked
immunosorbent assay (ELISA) titers were determined, as described below, from two systematic-randomly selected steers within each pen (72 cattle in total). The systematic-random selection
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TABLE 1. Study timetable
Date

Feedyard Treatment
(2004)
days
days
19 May
15 Jun.
6 Jul.
27 Jul.
10 Aug.
24 Aug.
7 Sep.
21 Sep.
22 Sep.

23 Sep.

Posttreatment
days
Description
Placed into
feedyard
First treatment dose
Second treatment dose
Third treatment dose
Test period 1
Test period 2
Test period 3
Test period 4
Harvest

Completion
of harvest

Samples
collected

Blood, feces

Blood, feces
Feces
Feces
Blood, feces
Terminal
rectum
mucosa
Terminal
rectum
mucosa

process was to randomly assign the eight steers from each pen a
value of one to eight and then select serum from animals with the
same two randomly selected values (e.g., steers 3 and 6 from each
pen).
Samples of terminal rectum mucosal (TRM) cells were collected at the abattoir. Following evisceration of the animal, an
abattoir worker removed the terminal 20 to 30 cm of the large
intestine and placed it into a plastic bag, along with an identification tag. Minutes later, at a separate location in the abattoir,
laboratory workers made an incision lengthwise along the excised
large intestinal segment to expose the mucosal surface and removed the contents with a sterile wooden tongue depressor. Following removal of all visible material from the lumen and mucosal surface, a 2.5-cm-wide circumferential band of TRM cells,
extending from 3.0 to 5.5 cm proximal to the rectoanal junction,

FIGURE 1. Use of a sterile glass microscope slide to obtain tenninal rectum mucosal (TRM) cells from a 2.5-cm-wide circumferential band extending from 3.0 to
5.5 cm proximal to the rectoanal junction.

-

was obtained by scraping with a sterile glass microscope slide
(Fig. 1). Approximately 1.5 g of TRM cells was harvested from
each animal and placed in 15 ml of chilled, modified Cary-Blair
transport media (ParaPak C & S, Meridian Bioscience, Inc., Cincinnati, Ohio). Transport media vials were submitted to the laboratory on ice and refrigerated (4°C) until TRM cells were cultured. TRM cells were cultured within 24 h after collection from
the animal. Sample collectors and laboratory personnel were
blinded to the treatment of the animals.
Feedlot performance outcomes of average daily gain, daily
DM intake, and feed efficiency were calculated from individual
(average daily gain) and pen-level measures. Carcass characteristic
outcomes were obtained from individual cattle at harvest and included the hot carcass weight, 12th-rib fat thickness, U.S. Department of Agriculture (USDA) marbling score, and USDA yield
grade. Carcass weights were recorded immediately prior to washing and placement of the carcass in the cooler. After the carcass
was chilled for 24 h, fat thickness, marbling score, and yield grade
were recorded. Marbling score is indicative of intramuscular fat
at the 12th rib and recorded on a scale of 300 = slight marbling
(USDA select quality grade) and 400 = small marbling (USDA
low choice quality grade). Yield grade measures are based on a
scale of 1 to 5. Yield grade is an estimate of boneless, closely
trimmed retail cuts, with a yield grade 1 having more retail yield
than a yield grade 5, which is much less lean with more fat.

Culture methods. Samples of feces and TRM cells were
cultured to assess for shedding and intestinal colonization, respectively. Fecal samples were cultured for E. coli 0157:H7 by
procedures that have been previously described (57). For each
fecal sample, a 10-g aliquot was added to 90 ml of gram-negative
broth containing vancomycin at 8 ~ g l m l cefixime
,
at 50 nglml,
and cefsulodin at 10 pglml and incubated at 37OC for 6 h. After
incubation, 1 ml of culture broth was removed and subjected to
E. coli 0157 immunomagnetic separation (Dynal, Lake Success,
N.Y.). Twenty microliters of the final immunomagnetic separation
suspension was plated on sorbitol MacConkey agar containing
cefixime (0.05 pglml) and tellurite (2.5 pglml). Three isolated,
non-sorbitol-fermenting colonies per plate were picked and reisolated on plates containing sorbitol MacConkey agar containing
-1
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cefixime (0.05 pglml) and tellurite (2.5 pg/ml) to ensure the purity of isolates. One well-isolated nonsorbitol-fermenting colony
was picked from each subculture and inoculated onto Fluorocult
(EM Science, Gibbstown, N.J.) and MacConkey agars and into
MacConkey broth and E. coli broth, the last to which 4-methylumbelliferyl-P-D-glucuronide had been added. Isolates that fermented lactose but were negative for P-glucuronidase activity
both by Fluorocult and E. coli broth culture were subjected to
latex agglutination tests for E. coli 0157 and H7 antigens (Remel,
Lenexa, Kans.). Isolates that agglutinated anti-0157-coated latex
beads, regardless of H7 agglutination results, were tested further
by multiplex PCR. The multiplex PCR was a five-primer-pair assay that has been previously described (50) but detects the presence of rfbE0157:H7(46), fliCh7 (18), stxl (45), stx2 (477, and
eaeo157 (19). The rfbE0157:H7gene encodes an enzyme required
for the synthesis of the E. coli 0157 antigen (4, 46); the eaeo15,
gene encodes intimin of E. coli 0157:H7 origin and is relatively
0 serogroup-specific (19);and the fliCh7 gene encodes the structural protein of the H7 flagellum (18). Confirmation of an isolate
being E. coli 0157:H7 was dependent on a positive reaction for
both rfbE0157:H7
and fliCh7 and at least one of the virulence factor
genes (i.e., stxl, stx2, or eae0157).Use of these criteria allows the
detection of E. coli 0 157:H7 strains that have lost stx or eaeo157
genes and also circumvents the ambiguity associated with the nonmotile designation (18).
TRM cell suspensions in transport media were cultured by
enrichment by adding 5 ml of suspension to 45 ml of gram-negative broth containing vancomycin at 8 pglml, cefixime at 50 ngl
ml, and cefsulodin at 10 pg/ml and incubating for 6 h at 37°C.
Procedures to isolate and identify E. coli 0157:H7 from the TRM
cell enrichment' cultures were identical to those described above
for the fecal cultures. Fecal and TRM isolates that, collectively,
were sorbitol nonfermenting, lactose fermenting, negative for Pglucuronidase activity, and positive for the 0157 antigen were
tested in the five-primer-pair multiplex PCR assay, as described
above. As noted above, detection of genes for 0157, H7, and at
least one other target in the assay was considered confirmation of
an isolate as E. coli 0157:H7.

Indirect ELISA to detect serum antibodies to type 111 secreted proteins. Serum antibody titers to E. coli 0157:H7 antigens, including EspA, EspB, translocated intimin receptor (Tir),
intimin, and 0157 lipopolysaccharide (LPS), were determined on
two steers from each of the 18 pens in the A and B treatment
groups. The indirect ELISA was conducted by a modification of
procedures previously described (34). E. coli BL21 ADE3 lysogens transformed with recombinant pET28a His-tag expression
vectors (Novagen, EMD Biosciences-Merck, San Diego, Calif.)
containing cloned tir-cesT, eae, espA, or espB genes were provided by Dr. B. Brett Finlay. Purified His-tagged proteins were obtained from these strains by standard procedures (Novagen HisBind Kit). The region of the eae gene cloned into the recombinant
intimin construct encoded the 280-carboxyl-terminal amino acids,
specific for the y-intimin subtype. The source of E. coli 0157
LPS was E. coli 0157:H7 strain 86-24, obtained by phenol-water
extraction and purified by standard methods (24).Individual wells
of microtiter plates were coated with 100 p1 of EspA (150 ng),
EspB (250 ng), Tir (100 ng), intimin (200 ng), or 0157 LPS (200
ng) in a 0.1 M carbonate solution and incubated overnight at 4OC.
Wells were washed four times, blocked overnight at 4°C with
60°C heat-treated 1% bovine serum albumin in 0.1 M carbonate
solution, and washed as described above. Twofold serial dilutions
of sera from 1:100 to 1:204,800 were made, and 100 p1 of each
dilution was added to wells in duplicate. Plates were incubated

for 3 h at 37°C and washed and blocked as described above. One
hundred microliters of a 1:5,000 dilution of affinity-purified,
horseradish peroxidase-conjugated, H +L goat anti-bovine IgG
(Jackson ImmunoResearch Laboratories, West Grove, Pa.) was
added to each well, and then plates were incubated for 1 h at 37°C
and washed four times. One hundred microliters of orthophenylenediamine (1 mglml) was added, and plates were incubated at
room temperature for 20 min. Fifty microliters of 3 M o-phosphoric acid was added, and A492was measured. The antibody titer
was the highest dilution having an absorbance (mean minus 1
SEM) greater than the negative control (mean plus 1 SEM), the
latter of which included all reagents except primary serum.

Statistical analyses. The effect of vaccine treatment on the
probability to detect E. coli 0157:H7 from feces was tested by
multivariable modeling of the number of culture-positive individuals per number of individuals within the pen with a logit link,
binomial distribution, generalized estimation equation (GEE)
model (Proc GENMOD, SAS Institute, Cary, N.C.). A first-order
autoregressive correlation structure was defined to account for
clustering by repeated measures of pens over time. The models
were fashioned by a manual forward selection process with the
opportunity for subsequent backward elimination so that variables
in the final model were significant at a 5 0.05 with the score
statistic for type 3 GEE analysis. Fixed effects tested in the model
were vaccine treatment, dietary treatment, and test period. Twoway interactions between these variables were also tested. Model
fit was assessed by evaluating the deviance parameter.
The effect of vaccine treatment on the probability of colonization was tested by multivariable modeling of the number of
TRM culture-positive individuals per number of individuals within the pen with a logit link function, binomial distribution, GEE
model (Proc GENMOD, SAS). Compound symmetry was the defined correlation structure to account for the clustering of animals
within a pen. The model was fashioned by a manual forward
selection process with subsequent backward elimination so that
variables in the model were significant at a I0.05 by the score
statistic for type 3 GEE analysis. Fixed effects tested in the model
were vaccine and dietary treatment. Model fit was assessed by
evaluating the deviance parameter.
Least-squared means of the parameter estimates from logistic
regression models were used to estimate model-adjusted probabilities of E. coli 0157:H7 outcomes for the levels of each class
variable in the model. Relative risk values for vaccine treatment
were calculated from the model-adjusted probabilities, and vaccine efficacy was calculated as 1 minus relative risk.
Serum antibody titers were log2 transformed prior to statistical analysis. The effect of vaccination on the magnitude of titer
change from prevaccination until either (i) 14 days after the vaccine regimen was completed or (ii) the day of harvest (56 days
after the vaccine regimen was completed) was tested in a generalized linear mixed model (Proc MIXED, SAS) with pen as a
random effect. The effect of vaccination on the probability of a
fourfold (2 log2) or greater titer change from prevaccination until
either (i) 14 days after the vaccine regimen was completed or (ii)
the day of harvest was tested in a logit link function, binomial
distribution, GEE model (Proc GENMOD, SAS), accounting for
a compound symmetry correlation structure by pen. Statistical significance was at a I0.05. Model fit was assessed by evaluating
the deviance parameter.
The effect of vaccination on feedlot performance outcomes
of average daily gain, daily DM intake, and feed efficiency was
evaluated in generalized linear mixed models (Proc MIXED,
SAS). Pen was the experimental unit. Fixed effects were vacci-
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FIGURE 2. Mean probability that cattle will shed E. coli 0157:
H7 in feces at each of the posttreatment test periods for vaccinated (solid diamond) and placebo-treated (hollow square) pens
of cattle. The greatest probability of shedding in either treatment
group occurred simultaneously with a 6.4-cm rain event on 21
September, 1 day prior to harvest. Error bars represent 1 standard error.

nation and dietary treatment. Treatment means were considered
significantly different at a i 0.05.
The effect of vaccination on individual carcass characteristics
of hot carcass weight, 12th-rib fat thickness, marbling score, and
yield grade was evaluated in a generalized linear mixed model
(Proc MIXED, SAS). Fixed effects were vaccination and dietary
treatment. Treatment means were considered significantly different
at a 5 0.05. Pen was included in the model as a random effect.
Observations from cattle that were held 1 additional day before
harvest were excluded from carcass data analysis.

RESULTS
Five steers were removed (n = 2 vaccinated, n = 3
placebo) from the trial prior to the first test period sampling
because of receiving the wrong vaccine (n = 3) or factors
unrelated to the study (n = 2). All steers on trial were fed
for 126 days and were sent to harvest on 21 September
2004; however, a scheduling error at the abattoir prevented
all from being harvested on the same day. Two hundred
forty-seven steers were harvested on 22 September, and the
remaining 36 were harvested on 23 September. All cattle
harvested on the second day were vaccinated steers. TRM
cell samples were not collected from two vaccinated steers
harvested on 22 September, most likely because the identification tags were lost.

Fecal cultures. E. coli 0157:H7 was recovered from
90 (6.4%) of 1,410 fecal samples. During the pretreatment
sampling period, the mean pen-level prevalences of steers
shedding E. coli 0157:H7 within the vaccinated and placebo-treated pens were 6.3 and 1.4%, respectively (P =
0.07). The probability that steers would shed E. coli 0157:
H7 at the start of the trial was not significantly different by
dietary treatment assignments (P = 0.92). E. coli 0157:H7

FIGURE 3. Correlation between prevalence of E. coli 0157 in
feces and terminal rectum mucosa 1 day later from pens of placebo-treated cattle. Prevalence of the two measures was positively
correlated (r = 0.60, P = 0.008). The solid line represents the
least-squares linear regression.

was cultured from 79 of 1,127 fecal samples obtained during the postvaccination test periods. The mean pen-level
prevalence of E. coli 0157:H7 isolated from feces was 4.6,
5.0, 6.0, and 12.4%, respectively, for test periods corresponding to 14, 28, 42, and 56 days after completion of the
three-dose regimen. A total of 36 (6.4%) of 564 samples
were from vaccinated steers, and 43 (7.5%) of 563 were
from placebo-treated steers. At each of the three posttreatment test periods prior to the last sampling date, the posttreatment prevalence of fecal shedding was lower among
vaccinated cattle than placebo-treated cattle (P = 0.07).
However, this picture changed during the last sampling period in the feedyard (Fig. 2). At the last test period, the
prevalence of fecal shedding among vaccinated cattle was
greater than during previous periods. A major rain event
(6.4 cm of rain) occurred in the early hours of 21 September prior to testing. On the day prior to sampling (20 September), the pen surface condition score of every pen on
study was recorded as dry and dusty, but prior to sampling
cattle on 21 September, the pen surface conditions for all
pens were recorded as extremely wet and muddy.
When all four posttreatment periods were considered
in the analysis, neither vaccination treatment (odds ratio
[OR] = 0.81, P = 0.57), diet (P = 0.41), nor test week (P
= 0.58) significantly explained the probability that cattle
would shed E. coli 0157:H7 in the feces.

Culture of TRM cells. Samples of TRM cells were
collected from 281 steers at harvest. A total of 1 (0.71%)
of 140 TRM cell samples collected from vaccinated cattle
tested positive for E. coli 0157:H7, whereas 38 (27.0%) of
141 TRM cell samples collected from placebo-treated cattle
tested positive. Within placebo-treated pens, the prevalence
of fecal shedding prior to loading cattle for harvest on 21
September correlated with the prevalence of colonization at
harvest 1 day later (r = 0.60, P < 0.008; Fig. 3).
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TABLE 2. Multivariable logistic regression model of the probability of culturing E. coli 0157:H7 from samples of terminal rectum mucosal cells from steers vaccinated against E. coli 0157:

placebo-treated steers, respectively. Vaccine efficacy for
preventing colonization was 98.3%.

Serology. At the time of the first vaccination, all cattle
in the study were seropositive for each of the E. coli 0157:
H7 antigens tested, but the titers were not significantly different between the two treatment groups. From prevaccination to 14 days after completion of treatment regimen (Fig.
4), the magnitudes of the seroresponse (change in log2 titer
values) of vaccinated cattle were 0.89 and 3.03 to Tir (P
= 0.04) and 0157 LPS (P < 0.0001), respectively. Similarly, during the same period, vaccinated cattle had significantly greater probabilities for a fourfold or greater seroresponse to Tir (OR = 2.7, P = 0.04) and 0157 LPS (OR
= 8.0, P < 0.0001) than placebo-treated cattle. From prevaccination to harvest (Fig. 4), vaccinated cattle had a significantly greater magnitude of seroresponse (P = 0.0008)
and greater probability of a fourfold or greater seroresponse
(OR = 4.9, P = 0.003) to 0157 LPS. However, neither the
magnitude of seroresponse to Tir (P = 0.23) nor the probability of a seroresponse (P = 0.46) was significantly different from prevaccination to harvest. From prevaccination
to 14 days after treatment regimen, the magnitudes of the
seroresponse of vaccinated cattle were 0.44, 0.58, and 0.22
greater than those of placebo-treated cattle to EspA (P =
0.30), EspB (P = 0.10), and intimin (P = 0.57), respectively. Similarly, the probabilities of a fourfold or greater
seroresponse to EspA (OR = 1.15, P = 0.81), EspB (OR
= 2.07, P = 0.17), and intimin (OR = 0.63, P = 0.46) in
vaccinated cattle were not significant compared with placebo-treated cattle.

H7 or treated with placebo and fed in a research feedloFb

Variable

Unit

Intercept
Vaccination Vaccine
Placebo
Diet
10DG
20DG
30DG
40DG
50DG
OODG
a

Parmeter
estimate

Odds
ratio

-0.914
-4.2881
0
-1.4544
- 1.4994
-2.'192
0.945
1.3413
0

0.014
1.OO
0.23
0.22
0.1 1
2.57
3.82
1.OO

95%
confidence
interval

2573

P value

0.03
0.002 0.085 <0.0001
Referent
0.03 1.57
0.04
0.07 0.75
0.02 0.70
0.92 7.17
0.98 14.99
Referent

IODG, 10% distillers' grains in finishing diet; 20DG, 20% distillers' grains in finishing diet; 30DG, 30% distillers' grains in
finishing diet; 40DG, 40% distillers' grains in finishing diet;
50DG, 50% distillers' grains in finishing diet; OODG, no distillers' grains in finishing diet.
Deviance parameter divided by degrees of freedom = 0.78, indicating slight underdispersion in the model.

The factors explaining the probability that TRM cell
samples from steers would test culture positive for E. coli
0157:H7 in the multivariable logistic regression model (Table 2) were vaccination treatment (OR = 0.014, P <
0.0001) and diet (P = 0.04). There was no significant interaction between diet and vaccination treatment, vaccination and test period, or diet and test period. The modeladjusted probability of E. coli 0157:H7 colonization in the
terminal rectum was 0.003 and 0.199 for vaccinated and

Feedlot performance and carcass characteristics.
There was no interaction between diet and vaccination
treatment for feedlot performance or carcass characteristic

FIGURE 4. Geometric mean antibody titers against specijic antigens measured
from serum collected from a subset of vaccinated and placebo-treated cattle at various days in the feedyard. Feedlot days 28,
84, and 126 correspond to the day of jrst
treatment, 14 days after completing the
treatment regimen, and the last day in the
feedyard (56 days after completing the
treatment regimen), respectively.
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outcomes. Feedlot performance, adjusted for dietary treatment, was not significantly different among vaccinated and
placebo-treated pens of steers. Initial trial BW averaged 352
kg ( P = 0.89). Final live BW was not different ( P = 0.92)
and averaged 584 kg for vaccinated and placebo-treated
steers. Daily DM intake averaged 11.00 kg for vaccinated
cattle and 11.15 kg for placebo-treated cattle ( P = 0.24).
Average daily gains were 1.84 and 1.85 kg (P = 0.87) for
vaccinated and placebo-treated pens of steers, respectively.
Feed efficiency averaged 0.167 for vaccinated pens of
steers and 0.165 ( P = 0.45) for placebo-treated pens of
steers.
Carcass characteristics of hot carcass weight, 12th-rib
fat thickness, and USDA yield grade for vaccinated and
placebo-treated steers, adjusting for diet, were not significantly different for vaccinated or placebo-treated steers. Hot
carcass weight averaged 366 kg for vaccinated cattle and
369 kg for placebo-treated cattle ( P = 0.32). Fat thickness
averaged 1.26 cm for vaccinated cattle and 1.22 cm for
placebo-treated cattle ( P = 0.40). Yield grade averaged
2.57 for vaccinated cattle and 2.69 for placebo-treated cattle
(P = 0.16). Paradoxically, the USDA marbling score did
differ between treatment groups. The marbling score averaged 405 for vaccinated cattle and 423 for placebo-treated
cattle ( P = 0.05).

DISCUSSION
The most important finding of this study was that vaccinated cattle were less likely to be colonized at the TRM.
We assessed vaccine efficacy by determining the extent to
which colonization of the TRM was prevented, because this
is an important site of colonization (41, 42). To our knowledge, this is the first report to evaluate a preharvest intervention for the control of E. coli 0157:H7 with colonization of TRM as the outcome variable. This finding is consistent with the hypothesized mode of action of this vaccine. It was unfortunate, but unavoidable, that problems at
the plant required a delay in harvesting TRM cells from
some cattle. However, the data provide no evidence of bias
resulting from this delay.
Vaccines designed to protect humans and animals
against E. coli and other enteric infections are, in general,
aimed at preventing intestinal colonization and often require the ability to induce a significant mucosal immune
response to be efficacious (33, 43). The primary targets of
E. coli vaccines that attempt to prevent intestinal colonization are bacterial adherence factors (61). For E. coli
0157:H7, proof-of-concept studies have shown that antibodies directed against intimin, an adherence factor known
to play a significant role in colonization in different species,
including adult cattle (9, 37), reduce bacterial adherence to
epithelial cells, both in vitro and in vivo (12, 20). LEEencoded type I11 secreted proteins, including Tir, are also
important for colonization of the bovine intestine (42), and
Tir is thought to mediate its effect on colonization primarily
by binding to the C-terminal region of intimin (64).Further,
antibodies to EspA, another type I11 secreted protein involved in initial adherence and attaching-effacing lesion development, block development of these lesions. (30).
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In a previous study, a vaccine containing type I11 secreted proteins effectively reduced the probability that feedlot steers would test positive for E. coli 0157:H7 in the
feies (50). In the present study, however, we were unable
to observe significant differences between vaccinated and
placebo-treated cattle in the probability of detecting E. coli
0157:H7 from feces. However, the overall probability of
detecting E. coli 0157:H7 among placebo-treated cattle in
this study was very low compared with our previous observations of untreated cattle in research and commercial
feedyards (27, 50, 57). The present study was designed with
sufficient power to detect differences similar to those observed in an earlier study (50) in the same feedlot during
a similar time of year; however, the probability of detecting
E. coli 0157:H7 in the feces of placebo-treated cattle
(21.3%) in that study was greater than what was observed
in the present study (7.5%). Other researchers who investigated a vaccine containing type I11 secreted proteins in a
large-scale commercial feedyard study did not find significant differences in the fecal shedding of E. coli 0157:H7
between vaccinates and nonvaccinates, possibly because of
low overall shedding prevalence, large within-pen variability, and a different vaccine formulation (viz. formalin-treated antigen) (63).
Regardless of the overall low probability of cattle shedding E. coli 0157:H7 in feces throughout the study, a
weather event may have had the greatest impact on our
ability to observe treatment differences in fecal shedding.
Immediately prior to harvest, vaccinated and placebo-treated cattle were suddenly exposed to wet and muddy pen
conditions, which have been shown to provide a greater
opportunity for fecal-oral transmission of E. coli 0157:H7
(57, 58). We suspect the organisms we isolated from the
feces were simply passing through the intestinal tract, and
the rain event serendipitously provided an opportunity to
witness the colonization outcome following the sudden oral
challenge. In the feedlot, prior to loading, cattle from both
treatment groups shed organisms in feces at the highest rate
of the study; however, at harvest, vaccinated cattle were
significantly less likely to be detected as colonized than
placebo-treated controls. This finding is consistent with the
proposed mechanism of action of this vaccine product (50),
previous longitudinal studies showing a wide variation in
shedding prevalence over time (27, 50), and the relationship
between weather-related factors and the feedlot occurrence
of E. coli 0157:H7 (58).
The vaccine used in this study was prepared from culture supernatant, and the primary intended antigens were
type 111 secreted proteins, although 0157 LPS was also
present. Although we did not attempt to measure antibodies
to type I11 secreted proteins in intestinal secretions, we did
determine that vaccination induced a significant IgG seroresponse to Tir and 0 157 LPS. IgGl plays a highly significant role in mucosal immunity in cattle and other ruminants, in addition to secretory IgA; in cattle, IgGl is actively secreted across epithelial surfaces, including the intestinal mucosa (5). In cattle, subcutaneous immunization
induces significant IgG1, IgM, and IgG2 seroresponses
(51).In adult humans, immunization with an investigational
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vaccine consisting of E. coli 0157 0-specific polysaccharide-Pseudomonas aeruginosa recombinant exoprotein A
conjugate induced high titers of serum bactericidal activity
that roughly correlated with the serum IgG and IgM antibody levels (28).
We speculate that, in vaccinated cattle, antibodies to
type I11 secreted proteins and possibly other bacterial components (e.g., 0157 LPS) were transported into the intestinal lumen and blocked colonization. We further speculate
that colonization was prevented or reduced by interference
with attaching-effacing lesion formation and possibly other
adherence mechanisms. In two previous studies, we found
that this vaccine product reduced the probability of E. coli
0157:H7 fecal shedding in cattle (49, 50). Antibodies to
0157 LPS are also known to mediate bactericidal activity
against E. coli 0157:H7 through complement-mediated lysis and could play a role in mucosal immunity by killing
bacteria in the intestinal lumen and on the surfaces of epithelial cells (28, 40). An additional role for anti-0157 antibodies could be to enhance the opsonization of bacteria.
However, a previous study had reported that serum antibody titers to 0157 LPS were not correlated with reduced
fecal shedding or protection against repeat challenge in cattle (25).
The probability of detecting E. coli 0 157:H7 in TRM
cells from cattle was different for cattle fed different levels
of DG. In a previous study, dietary substitution of dryrolled corn with corn bran and wet corn gluten feed did not
affect the probability that cattle would shed E. coli 0157:
H7 in the feces (36). However, more recently, we found
that the corn component of the diet affected the probability
that cattle would test positive for E. coli 0157:H7 in feces
(49). A variety of diets and dietary components have been
associated with the probability that cattle and sheep would
shed E. coli 0157:H7 in feces (14, 15, 29, 54). However,
the mechanisms by which diet or diet components might
affect E. coli 0157:H7 fecal shedding patterns are unclear.
Feedlot performance and carcass characteristics did not
differ between vaccinated and placebo-treated cattle with
the exception of marbling score. It is unclear why, in this
study, marbling was decreased among vaccinated cattle
without the observation of other carcass or performance
effects. Further, in two other studies with larger numbers
of cattle, we did not observe an effect of vaccination on
marbling score (49, 56). Therefore, we believe the observation in the present study is a spurious result from examining multiple carcass outcomes.
Results from this study suggest that this vaccine product effectively reduces the probability that cattle will become colonized by E. coli 0157:H7 in TRM cells under
conditions of natural exposure, a first step in its evaluation
as an effective intervention for food and environmental
safety.
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